Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
How would you approach early stage NSCLC in a patient who is not an ideal surgical candidate and has pulmonary AVMs?
Related Questions
Would you treat a patient with an N2 ipsilateral recurrence following re-resection of bronchial stump recurrence?
What are your top takeaways in thoracic cancers from ESMO 2025?
How would you manage a patient with non-mutated oligometastatic NSCLC with a brain met who underwent resection of the brain met, had 4 cycles chemoIO, and had resection of the primary lung CA with pCR and now is NED?
What target expansions do you use when treating with 60 Gy in 15 fractions for the lung?
Is there a role for the addition of radiation to preoperative chemoimmunotherapy in NSCLC with limited N2 disease planned for surgery?
How do you approach the treatment of LS-SCLC after SBRT for a prior NSCLC in the ipsilateral lung?
Can symptomatic radiation pneumonitis ever improve spontaneously without corticosteroids?
In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?
Do you offer consolidation durvalumab in a patient who had pneumonitis requiring steroids following chemoradiation for LS-SCLC?
Would you offer empiric lung SBRT for two growing FDG-avid lung lesions in a patient with severe COPD on oxygen?
